(Q39695999)

14 September 2017

title

Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response (English)

1 reference

14 September 2017

0 references

0 references

1 reference

1 reference

Siew-Min Ong

1

1 reference

14 September 2017

Yann-Chong Tan

2

1 reference

14 September 2017

Ottavio Beretta

3

1 reference

14 September 2017

Dongsheng Jiang

4

1 reference

14 September 2017

Wei-Hseun Yeap

5

1 reference

14 September 2017

June J Y Tai

6

1 reference

14 September 2017

Wing-Cheong Wong

7

1 reference

14 September 2017

Henry Yang

8

1 reference

14 September 2017

Herbert Schwarz

9

1 reference

14 September 2017

Kiat-Hon Lim

10

1 reference

14 September 2017

Poh-Koon Koh

11

1 reference

14 September 2017

Khoon-Lin Ling

12

1 reference

14 September 2017

Siew-Cheng Wong

13

1 reference

14 September 2017

language of work or name

English

0 references

publication date

12 December 2011

1 reference

European Journal of Immunology

14 September 2017

published in

1 reference

14 September 2017

volume

42

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

89-100

1 reference

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Distinct role of macrophages in different tumor microenvironments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Macrophage polarization in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Brave little world: spheroids as an in vitro model to study tumor-immune-cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Cell and environment interactions in tumor microregions: the multicell spheroid model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Tuning inflammation and immunity by chemokine sequestration: decoys and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Expression and functional role of CD54/Intercellular Adhesion Molecule-1 (ICAM-1) on human blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Dual role of macrophages in tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Clinical Use of Interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Production of interferon-gamma by myeloid cells--fact or fancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Involvement of TWEAK in interferon gamma-stimulated monocyte cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Primary antitumor immune response mediated by CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Coordination of intratumoral immune reaction and human colorectal cancer recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Interferon-alpha, -beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: modulation by peroxisome proliferator-activated receptor-gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Tumor-infiltrating T lymphocytes: friends or foes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

High macrophage infiltration along the tumor front correlates with improved survival in colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Bioconductor: open software development for computational biology and bioinformatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Identifying differentially expressed genes using false discovery rate controlling procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

TM4 microarray software suite

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

Linear models and empirical bayes methods for assessing differential expression in microarray experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

inferred from DOI database lookup

7 January 2021

based on heuristic

TM4: a free, open-source system for microarray data management and analysis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141825

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/EJI.201141825

1 reference

14 September 2017

1 reference